| 摘要 |
The disclosure provides compounds, methods, and kits for diagnosis, detection, screening, and imaging of a disease condition (e.g., infection, cancer, tumor, neoplasia), in vitro, ex vivo, and/or in vivo. Certain embodiments include administering a cationic steroid antimicrobial (a "CSA" or "ceragenin"), the CSA including a steroidal backbone and a heterocyclic ring separated from the steroidal backbone by at least 8 atoms, to a subject having or at risk of having a disease condition in an amount effective to diagnose, detect, screen for or image the disease condition in the subject. |
